Meridian Bioscience Promotes Tony Serafini-Lamanna to Executive Vice President of Diagnostics May 20, 2020 Read More
Meridian Bioscience Reports Second Quarter 2020 Operating Results; Raises Guidance on Strength of COVID-19 Related Products May 8, 2020 Read More
Meridian Bioscience Announces Closing of Transaction to Acquire Exalenz Bioscience April 30, 2020 Read More
Meridian Bioscience Simplifies COVID-19 Sample Prep and Eliminates Dependence on Reagents in Short Supply April 27, 2020 Read More
Meridian Bioscience To Hold Second Quarter 2020 Financial Results Conference Call On May 8, 2020 April 16, 2020 Read More
MERIDIAN BIOSCIENCE ANNOUNCES BETTER-THAN-EXPECTED PRELIMINARY SECOND QUARTER FISCAL 2020 REVENUE RESULTS WITH DOUBLE-DIGIT GROWTH April 2, 2020 Read More
Meridian Bioscience Supports Diagnostic Companies in Fighting Coronavirus Pandemic by Providing Zero Cost Proprietary Technology for Evaluation March 16, 2020 Read More
Meridian Bioscience Announces FDA-Clearance for New Curian™ Analyzer and the Curian™ HpSA® Assay March 16, 2020 Read More
